STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway

Siegel, 2020, Cancer statistics, 2020, CA Cancer J Clin, 70, 7, 10.3322/caac.21590 Herbst, 2008, Lung cancer, N Engl J Med, 359, 1367, 10.1056/NEJMra0802714 Altorki, 2019, The lung microenvironment: an important regulator of tumour growth and metastasis, Nat Rev Cancer, 19, 9, 10.1038/s41568-018-0081-9 Tomas, 2014, EGF receptor trafficking: consequences for signaling and cancer, Trends Cell Biol, 24, 26, 10.1016/j.tcb.2013.11.002 da Cunha Santos, 2011, EGFR mutations and lung cancer, Annu Rev Pathol, 6, 49, 10.1146/annurev-pathol-011110-130206 Ciardiello, 2008, EGFR antagonists in cancer treatment, N Engl J Med, 358, 1160, 10.1056/NEJMra0707704 Levkowitz, 1998, c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor, Genes Dev, 12, 3663, 10.1101/gad.12.23.3663 Huang, 2013, Lysine 63-linked polyubiquitination is required for EGF receptor degradation, Proc Natl Acad Sci U S A, 110, 15722, 10.1073/pnas.1308014110 Roberts, 2007, Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer, Oncogene, 26, 3291, 10.1038/sj.onc.1210422 McCullough, 2004, AMSH is an endosome-associated ubiquitin isopeptidase, J Cell Biol, 166, 487, 10.1083/jcb.200401141 McCullough, 2006, Activation of the endosome-associated ubiquitin isopeptidase AMSH by STAM, a component of the multivesicular body-sorting machinery, Curr Biol, 16, 160, 10.1016/j.cub.2005.11.073 Baiady, 2016, The Vps27/Hrs/STAM (VHS) domain of the Signal-transducing Adaptor Molecule (STAM) directs associated molecule with the SH3 domain of STAM (AMSH) specificity to longer ubiquitin chains and dictates the position of cleavage, J Biol Chem, 291, 2033, 10.1074/jbc.M115.689869 Tanaka, 1999, Possible involvement of a novel STAM-associated molecule "AMSH" in intracellular signal transduction mediated by cytokines, J Biol Chem, 274, 19129, 10.1074/jbc.274.27.19129 Davies, 2013, Mechanism of recruitment and activation of the endosome-associated deubiquitinase AMSH, Biochemistry, 52, 7818, 10.1021/bi401106b Gatta, 2019, The ESCRT-machinery: closing holes and expanding roles, Curr Opin Cell Biol, 59, 121, 10.1016/j.ceb.2019.04.005 Sierra, 2010, AMSH interacts with ESCRT-0 to regulate the stability and trafficking of CXCR4, J Biol Chem, 285, 13990, 10.1074/jbc.M109.061309 Agromayor, 2006, Interaction of AMSH with ESCRT-III and deubiquitination of endosomal cargo, J Biol Chem, 281, 23083, 10.1074/jbc.M513803200 Solomons, 2011, Structural basis for ESCRT-III CHMP3 recruitment of AMSH, Structure, 19, 1149, 10.1016/j.str.2011.05.011 Kyuuma, 2007, AMSH, an ESCRT-III associated enzyme, deubiquitinates cargo on MVB/late endosomes, Cell Struct Funct, 31, 159, 10.1247/csf.06023 Nakamura, 2006, Clathrin anchors deubiquitinating enzymes, AMSH and AMSH-like protein, on early endosomes, Genes Cells, 11, 593, 10.1111/j.1365-2443.2006.00963.x Ishii, 2001, Loss of neurons in the hippocampus and cerebral cortex of AMSH-deficient mice, Mol Cell Biol, 21, 8626, 10.1128/MCB.21.24.8626-8637.2001 McDonell, 2013, Mutations in STAMBP, encoding a deubiquitinating enzyme, cause microcephaly-capillary malformation syndrome, Nat Genet, 45, 556, 10.1038/ng.2602 Faqeih, 2015, Novel STAMBP mutation and additional findings in an Arabic family, Am J Med Genet A, 167A, 805, 10.1002/ajmg.a.36782 Hori, 2018, A novel homozygous missense mutation in the SH3-binding motif of STAMBP causing microcephaly-capillary malformation syndrome, J Hum Genet, 63, 957, 10.1038/s10038-018-0482-3 Wu, 2019, Earlyonset epilepsy and microcephalycapillary malformation syndrome caused by a novel STAMBP mutation in a Chinese boy, Mol Med Rep, 20, 5145 Bednash, 2017, Targeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity, Nat Commun, 8, 15203, 10.1038/ncomms15203 Hasdemir, 2009, Endosomal deubiquitinating enzymes control ubiquitination and down-regulation of protease-activated receptor 2, J Biol Chem, 284, 28453, 10.1074/jbc.M109.025692 Herrera-Vigenor, 2006, AMSH regulates calcium-sensing receptor signaling through direct interactions, Biochem Biophys Res Commun, 347, 924, 10.1016/j.bbrc.2006.06.169 Ribeiro-Rodrigues, 2014, AMSH-mediated deubiquitination of Cx43 regulates internalization and degradation of gap junctions, FASEB J, 28, 4629, 10.1096/fj.13-248963 Meijer, 2012, Recycling of EGFR and ErbB2 is associated with impaired Hrs tyrosine phosphorylation and decreased deubiquitination by AMSH, Cell Signal, 24, 1981, 10.1016/j.cellsig.2012.07.006 Ma, 2007, Targeting of AMSH to endosomes is required for epidermal growth factor receptor degradation, J Biol Chem, 282, 9805, 10.1074/jbc.M611635200 Iwakami, 2018, STAM-binding protein regulates melanoma metastasis through SLUG stabilization, Biochem Biophys Res Commun, 507, 484, 10.1016/j.bbrc.2018.11.068 Stearman, 2005, Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model, Am J Pathol, 167, 1763, 10.1016/S0002-9440(10)61257-6 Cerami, 2012, The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov, 2, 401, 10.1158/2159-8290.CD-12-0095 Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci Signal, 6, pl1, 10.1126/scisignal.2004088 Zhang, 2020, Deubiquitinase UCHL5 is elevated and associated with a poor clinical outcome in lung adenocarcinoma (LUAD), J Cancer, 11, 6675, 10.7150/jca.46146 Li, 2020, OTUD5 cooperates with TRIM25 in transcriptional regulation and tumor progression via deubiquitination activity, Nat Commun, 11, 4184, 10.1038/s41467-020-17926-7 Harrigan, 2018, Deubiquitylating enzymes and drug discovery: emerging opportunities, Nat Rev Drug Discov, 17, 57, 10.1038/nrd.2017.152 Zhang, 2020, Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance, J Cancer, 11, 2962, 10.7150/jca.39539 Riihimaki, 2014, Metastatic sites and survival in lung cancer, Lung Cancer, 86, 78, 10.1016/j.lungcan.2014.07.020 Planchard, 2018, Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 29, iv192, 10.1093/annonc/mdy275 Travis, 2011, International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma, J Thorac Oncol, 6, 244, 10.1097/JTO.0b013e318206a221 Sulahian, 2019, Synthetic lethal interaction of SHOC2 depletion with MEK inhibition in RAS-driven cancers, Cell Rep, 29, 118, 10.1016/j.celrep.2019.08.090 Terai, 2021, SHOC2 is a critical modulator of sensitivity to EGFR-TKIs in non-small cell lung cancer cells, Mol Cancer Res, 19, 317, 10.1158/1541-7786.MCR-20-0664 Lin, 2015, The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies, Nat Genet, 47, 250, 10.1038/ng.3218 Kurppa, 2020, Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway, Cancer Cell, 37, 104, 10.1016/j.ccell.2019.12.006 Pao, 2010, Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer, Nat Rev Cancer, 10, 760, 10.1038/nrc2947 Gelsomino, 2013, Epidermal growth factor receptor tyrosine kinase inhibitor treatment in patients with EGFR wild-type non-small-cell lung cancer: the never-ending story, J Clin Oncol, 31, 3291, 10.1200/JCO.2013.50.2617 Menard, 2018, Reactivation of mutant-EGFR degradation through clathrin inhibition overcomes resistance to EGFR tyrosine kinase inhibitors, Cancer Res, 78, 3267, 10.1158/0008-5472.CAN-17-2195 Dykxhoorn, 2006, The silent treatment: siRNAs as small molecule drugs, Gene Ther, 13, 541, 10.1038/sj.gt.3302703 Tam, 2013, Advances in lipid nanoparticles for siRNA delivery, Pharmaceutics, 5, 498, 10.3390/pharmaceutics5030498 Cheng, 2020, Discovery of potent and selective Epidermal Growth Factor Receptor (EGFR) bifunctional small-molecule degraders, J Med Chem, 63, 1216, 10.1021/acs.jmedchem.9b01566 Leung, 2016, Targeting tyrosine kinase inhibitor-resistant non-small cell lung cancer by inducing epidermal growth factor receptor degradation via methionine 790 oxidation, Antioxid Redox Signal, 24, 263, 10.1089/ars.2015.6420 Yao, 2020, Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth, Signal Transduct Target Ther, 5, 214, 10.1038/s41392-020-00251-2 Conte, 2016, Chapter six - The ubiquitin network in the control of EGFR endocytosis and signaling, Prog Mol Biol Transl Sci, 141, 225, 10.1016/bs.pmbts.2016.03.002 Huang, 2006, Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain, Mol Cell, 21, 737, 10.1016/j.molcel.2006.02.018 Eden, 2012, The role of EGF receptor ubiquitination in regulating its intracellular traffic, Traffic, 13, 329, 10.1111/j.1600-0854.2011.01305.x